Whatman works with Clinton Foundation on HIV/AIDS Initiative

FLORHAM PARK, N.J. — Whatman, the global leader in separations technology, announces a donation of Neonatal Screening Cards to the Clinton HIV / AIDS Initiative (CHAI). The Whatman 903 Neonatal Cards were donated to CHAI for the collection of blood samples for early HIV / AIDS detection in infants in connection with CHAI's Pediatric Initiative. The 903 Neonatal Card is the recognized medical device for blood collection from infants for the screening of inherited metabolic disorders. Such testing is mandatory in the U.S. and in many countries globally for all newborn children.

"The donation of the 903 Neonatal Screening Cards has allowed CHAI to reach more children in developing nations in order to identify those children at risk for HIV / AIDS infection. With early detection these children can be treated with the life-saving medications they need to combat infection," says Maurine Murtagh, Director of Diagnostic Services, CHAI. Helen Evans, Whatman VP of Marketing, says "The donation has re-affirmed the commitment of Whatman to serving children in the detection of inherited and infectious disease."

About Whatman: A global leader in separations technology, Whatman provides innovative life science products and solutions for the scientific community. Whatman has developed total sample preparation solutions through our robust line of filtration devices and membranes. Whatman produces the 903 Neonatal Screening Cards to serve the needs of the global newborn screening market. The company's breakthrough protein array technology, coupled with unique innovations in capturing, archiving and purifying DNA at room temperature, enable us to provide novel solutions for the analytical, health care, and bioscience markets. For more information visit us at www.whatman.com.

About the Clinton HIV/AIDS Initiative: Launched in 2002 by former U.S. President Bill Clinton and the William J. Clinton Foundation, the Clinton HIV/AIDS Initiative (CHAI) assists countries in implementing large-scale, integrated care and treatment programs. It partners with 22 countries in Africa, the Caribbean, Asia, and Eastern Europe. Individual governments take the lead and CHAI provides technical assistance, mobilizes human and financial resources, and facilitates the sharing of best practices across projects. CHAI also provides access to reduced prices for HIV/AIDS drugs and diagnostics to 69 countries. Additional information is available on the Internet at www.clintonfoundation.org.